Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Stone

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
Blood|July 27, 2001
Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabineR M Stone, D T Berg, S L George, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2001
United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemiaS L Soignet, S R Frankel, D Douer, et al.
Leukemia|March 25, 2017
No evidence for microsatellite instability in acute myeloid leukemiaC J Walker, A-K Eisfeld, L K Genutis, et al.
Blood Cancer Journal|March 11, 2017
A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemiaG L Uy, M P Rettig, R M Stone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
CD6+ donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donorsR J Soiffer, E Weller, E P Alyea, et al.
Leukemia|July 4, 2015
Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AMLH Wu, C Hu, A Wang, et al.
Blood|November 23, 2000
Report of an international working group to standardize response criteria for myelodysplastic syndromesB D Cheson, J M Bennett, H Kantarjian, et al.
Leukemia|July 4, 2015
Somatic mutational landscape of AML with inv(16) or t(8;21) identifies patterns of clonal evolution in relapse leukemiaR Sood, N F Hansen, F X Donovan, et al.
Blood|May 23, 2001
High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)M R Baer, C C Stewart, R K Dodge, et al.
Leukemia|September 15, 2016
Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B Study (CALGB 10503)W Blum, B L Sanford, R Klisovic, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Blood|July 27, 2001
Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabineR M Stone, D T Berg, S L George, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2001
United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemiaS L Soignet, S R Frankel, D Douer, et al.
Leukemia|March 25, 2017
No evidence for microsatellite instability in acute myeloid leukemiaC J Walker, A-K Eisfeld, L K Genutis, et al.
Blood Cancer Journal|March 11, 2017
A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemiaG L Uy, M P Rettig, R M Stone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
CD6+ donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donorsR J Soiffer, E Weller, E P Alyea, et al.
Leukemia|July 4, 2015
Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AMLH Wu, C Hu, A Wang, et al.
Blood|November 23, 2000
Report of an international working group to standardize response criteria for myelodysplastic syndromesB D Cheson, J M Bennett, H Kantarjian, et al.
Leukemia|July 4, 2015
Somatic mutational landscape of AML with inv(16) or t(8;21) identifies patterns of clonal evolution in relapse leukemiaR Sood, N F Hansen, F X Donovan, et al.
Blood|May 23, 2001
High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)M R Baer, C C Stewart, R K Dodge, et al.
Leukemia|September 15, 2016
Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B Study (CALGB 10503)W Blum, B L Sanford, R Klisovic, et al.
Pageof 11